Handelsbanken Fonder
PRCT icon

Handelsbanken Fonder’s Procept Biorobotics PRCT Stock Holding History

Handelsbanken Fonder’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Buy
26,100
+8,300
+47% +$208K ﹤0.01% 1324
2026
Q1 		$445K Hold
17,800
– – ﹤0.01% 1331
2025
Q4 		$560K Buy
17,800
+3,300
+23% +$109K ﹤0.01% 1267
2025
Q3 		$518K Hold
14,500
– – ﹤0.01% 1247
2025
Q2 		$835K Hold
14,500
– – ﹤0.01% 1038
2025
Q1 		$845K Hold
14,500
– – ﹤0.01% 1007
2024
Q4 		$1.17M Sell
14,500
-1,100
-7% -$94K ﹤0.01% 902
2024
Q3 		$1.25M Buy
15,600
+3,500
+29% +$249K ﹤0.01% 855
2024
Q2 		$739K Buy
12,100
+400
+3% +$23.8K ﹤0.01% 979
2024
Q1 		$578K Buy
11,700
+1,400
+14% +$66.6K ﹤0.01% 1094
2023
Q4 		$432K Buy
10,300
+3,400
+49% +$116K ﹤0.01% 1217
2023
Q3 		$226K Hold
6,900
– – ﹤0.01% 1422
2023
Q2 		$244K Buy
+6,900
New +$228K ﹤0.01% 1431
2023
Q1 		– Sell
-5,100
Closed -$212K – 1578
2022
Q4 		$212K Buy
+5,100
New +$219K ﹤0.01% 1412

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Handelsbanken Fonder's PRCT Position: Q2 2026 in Review

Handelsbanken Fonder increased its Procept Biorobotics (PRCT) stake by 47% in Q2 2026, buying an estimated $208K and bringing the position to 26,100 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Handelsbanken Fonder first reported a position in PRCT in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.25M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Handelsbanken Fonder held 26,100 shares of Procept Biorobotics worth $589K as of Q2 2026.
  • Handelsbanken Fonder bought 8,300 Procept Biorobotics shares in Q2 2026, an estimated $208K.
  • Procept Biorobotics made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1324 holding.
  • Handelsbanken Fonder first reported a position in Procept Biorobotics in Q4 2022 and has held it in 14 quarters since.
  • Handelsbanken Fonder's Procept Biorobotics position peaked at $1.25M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.